The State of Texas Top Legal Officer Takes Legal Action Against Tylenol Manufacturers Regarding Autism Allegations

The top legal official in Texas Paxton is filing a lawsuit against the makers of Tylenol, asserting the corporations concealed safety concerns that the drug created to pediatric neurological development.

This legal action comes four weeks after President Donald Trump promoted an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in young ones.

Paxton is suing Johnson & Johnson, which formerly manufactured the drug, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he said they "betrayed America by making money from pain and marketing drugs without regard for the potential hazards."

The manufacturer says there is insufficient reliable data linking acetaminophen to autism.

"These companies deceived for years, intentionally threatening millions to line their pockets," Paxton, from the Republican party, declared.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the health of women and children in America."

On its website, Kenvue also stated it had "continuously evaluated the applicable studies and there is lacking reliable evidence that indicates a established connection between taking paracetamol and autism spectrum disorder."

Organizations acting on behalf of physicians and health professionals share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in acetaminophen - is a restricted selection for pregnant women to manage pain and elevated temperature, which can create major wellness concerns if ignored.

"In over twenty years of studies on the use of paracetamol in pregnancy, not a single reputable study has successfully concluded that the use of paracetamol in any stage of gestation leads to brain development issues in children," the organization stated.

This legal action mentions recent announcements from the former administration in claiming the drug is reportedly hazardous.

In recent weeks, Trump raised alarms from medical authorities when he told pregnant women to "struggle intensely" not to use acetaminophen when ill.

Federal regulators then published an announcement that doctors should contemplate reducing the usage of acetaminophen, while also stating that "a causal relationship" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary Kennedy, who supervises the FDA, had promised in spring to initiate "a massive testing and research effort" that would establish the source of autism in a limited time.

But experts cautioned that finding a sole reason of autism spectrum disorder - thought by researchers to be the result of a intricate combination of genetic and external influences - would be difficult.

Autism is a type of lifelong neurodivergence and impairment that influences how individuals perceive and relate to the surroundings, and is recognized using medical professional evaluations.

In his legal document, Paxton - a Trump ally who is seeking US Senate - alleges Kenvue and J&J "deliberately disregarded and attempted to silence the research" around acetaminophen and autism.

This legal action attempts to require the firms "remove any commercial messaging" that states Tylenol is safe for expectant mothers.

The Texas lawsuit mirrors the concerns of a collection of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of Tylenol in two years ago.

Judicial authorities dismissed the lawsuit, declaring research from the parents' expert witnesses was not conclusive.